Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00081570
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
CY0 | S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]- 3-OXOPROPYL}-L-CYSTEINE | A | 2J5E | 0.81 | |
3BI | (2S)-2-{[(R)-[(3R)-3-carboxy-3- {[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)carbonyl]amino}propyl](hydroxy)phosphoryl]methyl}pentanedioic acid | A | 3BI1 | 0.7 | |
RMC | (2R)-2-({6-[BENZYL(METHYL)AMINO]- 9-ISOPROPYL-9H-PURIN-2-YL}AMINO)BUTAN- 1-OL | A | 1YGJ | 0.72 | |
LIY | 6-ETHYL-5-[(2S)-1-(3-METHOXYPROPYL)- 2-PHENYL-1,2,3,4-TETRAHYDROQUINOLIN- 7-YL]PYRIMIDINE-2,4-DIAMINE | A,B | 2IKU | 0.7 | |
CC3 | N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN- 2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE | A | 2NP8 | 0.7 | |
LZJ | 6-(2,6-dibromophenyl)pyrido[2,3- d]pyrimidine-2,7-diamine | A,B | 2V58 | 0.72 | |
218 | 1-[(4-AMINO-2-METHYLPYRIMIDIN-5- YL)METHYL]-3-(2-HYDROXYETHYL)-2- METHYLPYRIDINIUM | A | 2HOP | 0.7 | |
S91 | [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN- 2-YL}AMINO)PHENYL]ACETIC ACID | A | 2Z8C | 0.72 | |
S91 | [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN- 2-YL}AMINO)PHENYL]ACETIC ACID | A | 2Z7L | 0.72 | |
MT1 | N-(4-{[(2,4-DIAMINOPTERIDIN-1-IUM- 6-YL)METHYL](METHYL)AMINO}BENZOYL)- L-GLUTAMIC ACID | A,B | 2INQ | 0.71 | |
DJK | N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN- 6-YL]-ACRYLAMIDE | A | 2J5F | 0.81 | |
DJK | N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN- 6-YL]-ACRYLAMIDE | A,B | 2HWP | 0.81 | |
SR2 | (2E)-N-{4-[(3-bromophenyl)amino]quinazolin- 6-yl}-4-(dimethylamino)but-2-enamide | A,B | 2QQ7 | 0.81 | |
SR2 | (2E)-N-{4-[(3-bromophenyl)amino]quinazolin- 6-yl}-4-(dimethylamino)but-2-enamide | A,B | 2QLQ | 0.81 | |
TRN | NZ2-TRYPTOPHAN | A,B,C | 1AM7 | 0.71 | |
UNN | (6,7-DIFLUORO-QUINAZOLIN-4-YL)- (1-METHYL-2,2-DIPHENYL-ETHYL)-AMINE | A,B,C | 5STD | 0.75 | |
GW3 | 7-(1-ETHYL-PROPYL)-7H-PYRROLO-[3,2- F]QUINAZOLINE-1,3-DIAMINE | A,B | 1AOE | 0.7 | |
RRC | R-ROSCOVITINE | A,B,C,D | 3DDQ | 0.72 | |
RRC | R-ROSCOVITINE | A | 1YGK | 0.72 | |
RRC | R-ROSCOVITINE | A | 1UNL | 0.72 | |
RRC | R-ROSCOVITINE | A | 2A4L | 0.72 | |
6IG | 6-ETHYL-5-[1-(3-METHOXYPROPYL)- 1,2,3,4-TETRAHYDROQUINOLIN-7-YL]- N~4~-(2-PHENYLETHYL)PYRIMIDINE- 2,4-DIAMINE | A,B | 2G22 | 0.71 | |
MQU | 7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]- 7H-PYRROLO[3,2-F] QUINAZOLINE-1,3- DIAMINE | A,B | 1M7A | 0.72 | |
SX2 | 4-[(5-bromopyridin-2-yl)amino]- 4-oxobutanoic acid | A,B | 3CJ0 | 0.73 | |
OLO | OLOMOUCINE | A | 4ERK | 0.71 | |
OLO | OLOMOUCINE | C | 1W0X | 0.71 | |
L1B | 7-(2,4-DIAMINO-6-ETHYLPYRIMIDIN- 5-YL)-1-(3-METHOXYPROPYL)QUINOLINIUM | A,B | 2G21 | 0.73 | |
MTX | METHOTREXATE | A,B | 1DRB | 0.73 | |
MTX | METHOTREXATE | A,B,C,D | 2C7V | 0.73 | |
MTX | METHOTREXATE | A | 1U70 | 0.73 | |
MTX | METHOTREXATE | A,B,C,D | 1MXF | 0.73 | |
MTX | METHOTREXATE | A | 2QK8 | 0.73 | |
MTX | METHOTREXATE | A,B | 1RB3 | 0.73 | |
MTX | METHOTREXATE | A,B | 1DHJ | 0.73 | |
MTX | METHOTREXATE | A | 3DAU | 0.73 | |
MTX | METHOTREXATE | A | 1U72 | 0.73 | |
MTX | METHOTREXATE | A,B | 2DRC | 0.73 | |
MTX | METHOTREXATE | A,B | 1D1G | 0.73 | |
MTX | METHOTREXATE | A,B | 1DDR | 0.73 | |
MTX | METHOTREXATE | A,B | 1E7W | 0.73 | |
MTX | METHOTREXATE | A | 1RX3 | 0.73 | |
MTX | METHOTREXATE | A | 3DFR | 0.73 | |
MTX | METHOTREXATE | A,B,C,D | 1P33 | 0.73 | |
MTX | METHOTREXATE | A | 3DAT | 0.73 | |
MTX | METHOTREXATE | A,B | 1DHI | 0.73 | |
MTX | METHOTREXATE | A,B | 1TDR | 0.73 | |
MTX | METHOTREXATE | A,B | 1DRA | 0.73 | |
MTX | METHOTREXATE | A | 3EIG | 0.73 | |
MTX | METHOTREXATE | A | 3CD2 | 0.73 | |
MTX | METHOTREXATE | A | 1AO8 | 0.73 | |
MTX | METHOTREXATE | A | 1DF7 | 0.73 | |
MTX | METHOTREXATE | A | 1DLS | 0.73 | |
MTX | METHOTREXATE | A | 1RG7 | 0.73 | |
MTX | METHOTREXATE | A | 1RH3 | 0.73 | |
MTX | METHOTREXATE | A,B | 4DFR | 0.73 | |
MTX | METHOTREXATE | A | 1RA3 | 0.73 | |
MTX | METHOTREXATE | A,B | 1DDS | 0.73 | |
MTX | METHOTREXATE | A | 1DRE | 0.73 | |
MTX | METHOTREXATE | A,B | 1AXW | 0.73 | |
MTX | METHOTREXATE | A | 3CL9 | 0.73 | |
MTX | METHOTREXATE | A,B | 3DRC | 0.73 | |
MTX | METHOTREXATE | A,B,C,D,E | 2OIP | 0.73 | |
LIH | 6-([5-QUINOLYLAMINO]METHYL)-2,4- DIAMINO-5-METHYLPYRIDO[2,3-D]PYRIMIDINE | A | 1KMS | 0.74 | |
5MS | N-{2-methyl-5-[(6-phenylpyrimidin- 4-yl)amino]phenyl}methanesulfonamide | A | 3EXO | 0.72 | |
TAQ | 2,4,6-TRIAMINOQUINAZOLINE | A,B,C,D,E,F, G,H | 1W0C | 0.74 | |
PYA | 3-(1,10-PHENANTHROL-2-YL)-L-ALANINE | A | 1HCW | 0.7 | |
4QB | 3-{2-ETHYL-6-[4-(QUINOXALIN-2-YLAMINO)- BENZOYLAMINO]-HEXANOYLAMINO}-4- OXO-BUTYRIC ACID | A | 1RWN | 0.7 | |
RBS | N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)- ACRYLAMIDE | A,B | 2HWO | 0.76 | |
LI8 | N-(3-{[5-BROMO-2-({3-[(PYRROLIDIN- 1-YLCARBONYL)AMINO]PHENYL}AMINO)PYRIMIDIN- 4-YL]AMINO}PROPYL)-2,2-DIMETHYLMALONAMIDE | A | 1Z5M | 0.71 | |
RC8 | (2R)-2-({9-(1-methylethyl)-6-[(4- pyridin-2-ylbenzyl)amino]-9H-purin- 2-yl}amino)butan-1-ol | A,C | 3DDP | 0.72 | |
RW1 | 4-phenylpyrimidine | A,B,C | 3B9S | 0.71 | |
OA4 | 5-methyl-6-phenylquinazoline-2,4- diamine | A | 2W6P | 0.71 | |
855 | 2-(6-methylpyridin-2-yl)-N-pyridin- 4-ylquinazolin-4-amine | A | 3HMM | 0.74 | |
PB3 | N,N'-BIS(3-METHYLBENZYL)PYRIMIDINE- 4,6-DICARBOXAMIDE | A,B | 1XUC | 0.7 | |
P5C | 2-{[(1R,2S)-2-aminocyclohexyl]amino}- 4-[(3-methylphenyl)amino]pyrimidine- 5-carboxamide | A | 3FQE | 0.71 |